Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Description
Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.
Investor Profile
Johnson & Johnson Development Corporation has made 160 investments, with 2 in the past 12 months and 17% as lead.
Stage Focus
- Series B (24%)
- Series C (23%)
- Series Unknown (15%)
- Series A (13%)
- Series D (11%)
- Series E (7%)
- Series F (3%)
- Post Ipo Equity (2%)
- Private Equity (1%)
- Seed (1%)
Country Focus
- United States (83%)
- Switzerland (4%)
- Denmark (3%)
- United Kingdom (3%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Belgium (2%)
- Canada (2%)
- Israel (1%)
- Estonia (1%)
- Australia (1%)
'/%3e%3c/defs%3e%3cpath fill='%23012169' d='M0 0h10080v5040H0z'/%3e%3cpath stroke='%23fff' stroke-width='.6' d='m0 0 6 3m0-3L0 3' clip-path='url(%23b)' transform='scale(840)'/%3e%3cpath stroke='%23e4002b' stroke-width='.4' d='m0 0 6 3m0-3L0 3' clip-path='url(%23c)' transform='scale(840)'/%3e%3cpath stroke='%23fff' stroke-width='840' d='M2520 0v2520M0 1260h5040'/%3e%3cpath stroke='%23e4002b' stroke-width='504' d='M2520 0v2520M0 1260h5040'/%3e%3cg fill='%23fff'%3e%3cuse xlink:href='%23d' x='2520' y='3780'/%3e%3cuse xlink:href='%23a' x='7560' y='4200'/%3e%3cuse xlink:href='%23a' x='6300' y='2205'/%3e%3cuse xlink:href='%23a' x='7560' y='840'/%3e%3cuse xlink:href='%23a' x='8680' y='1869'/%3e%3cuse xlink:href='%23e' x='8064' y='2730'/%3e%3c/g%3e%3c/svg%3e)
- The Netherlands (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Health Diagnostics
- Pharmaceutical
- Therapeutics
- Manufacturing
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
